Barrett J C
IARC Sci Publ. 1985(58):181-202.
The cellular and molecular basis for the multistep process of carcinogenesis can be studied in part by the use of cell culture models. A model system for the study of carcinogen-induced neoplastic transformation of cells in culture is described. Different stages in the neoplastic development of Syrian hamster embryo (SHE) fibroblasts can be identified and quantitated. At least two steps are required for the neoplastic progression of these cells. Morphological alterations are observed early after carcinogen treatment; such cells are preneoplastic and, after further growth in culture, acquire the ability to grow in agar and to form tumours in animals. The induction of morphological transformation of SHE cells occurs within one week after carcinogen treatment in a dose-dependent manner consistent with a one-hit mechanism. Furthermore, this change is induced at frequencies (greater than 1% of the surviving cells) that are higher than those of specific locus mutations. Carcinogens that fail to induce measurable gene mutations induce cell transformation (e.g., diethylstilboestrol, asbestos and arsenic). All three of these carcinogens induce chromosomal changes--either numerical and/or structural aberrations--suggesting a role for such changes in the action of these carcinogens. Different preneoplastic cells vary in the rate of their progression to anchorage-independent growth and tumorigenicity. Cells with the ability to grow in agar arise at rates of 10(-4) to 10(-7) variants/cell per generation, depending on the preneoplastic cell line. Different preneoplastic cell lines also vary in their sensitivity to induction of neoplastic transformation by mutagens and by transfection with viral oncogenes. This heterogenicity of response suggests different intermediate states of neoplastic progression.
致癌作用多步骤过程的细胞和分子基础可以部分地通过使用细胞培养模型来研究。本文描述了一种用于研究致癌物诱导培养细胞发生肿瘤转化的模型系统。叙利亚仓鼠胚胎(SHE)成纤维细胞肿瘤发展的不同阶段可以被识别和定量。这些细胞的肿瘤进展至少需要两个步骤。在致癌物处理后早期可观察到形态学改变;此类细胞是癌前细胞,在培养中进一步生长后,获得在琼脂中生长并在动物体内形成肿瘤的能力。SHE细胞形态转化的诱导在致癌物处理后一周内以与单 hit 机制一致的剂量依赖性方式发生。此外,这种变化的诱导频率(大于存活细胞的1%)高于特定基因座突变的频率。未能诱导可测量基因突变的致癌物可诱导细胞转化(例如,己烯雌酚、石棉和砷)。所有这三种致癌物都诱导染色体变化——数量和/或结构畸变——表明此类变化在这些致癌物的作用中发挥作用。不同的癌前细胞向不依赖贴壁生长和致瘤性进展的速率各不相同。根据癌前细胞系的不同,能够在琼脂中生长的细胞以每代10^(-4)至10^(-7)变体/细胞的速率出现。不同的癌前细胞系对诱变剂和病毒癌基因转染诱导肿瘤转化的敏感性也有所不同。这种反应的异质性表明肿瘤进展存在不同的中间状态。